drugset / Trial / NCT02223702

Alternative Antibiotic Regime in the Treatment of GAgP

NCT02223702

Phase 4 Completed 39 enrolled Kocaeli University
RandomizedParallel-groupDouble-blindSupportive care

Summary

The objective of this randomized clinical study was to evaluate the effect of systemic administration of moxifloxacin compared to amoxicillin plus metronidazole combined with non-surgical treatment in patients with generalized aggressive periodontitis (GAgP) in 6-month follow-up. A total of 40 systemically healthy patients with GAgP will evaluate in this randomized clinical trial. Periodontal parameters (plaque index, gingival index, probing depth, bleeding on probing, clinical attachment level) will be recorded at baseline, 1st, 3rd and 6th month. Patients will receive either 400 mg moxifloxacin per os once daily or 500 mg metronidazole and 500 mg amoxicillin per os three times daily for 7 days consecutively.

Timeline

Start
2011-05
Primary completion
2012-05
Completion
2014-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 500 mg Oral
Comparator Metronidazole Small molecule 500 mg
Subject Moxifloxacin Small molecule 400 mg Oral